• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff

cafead

Administrator
Staff member
  • cafead   Jun 30, 2024 at 10:02: PM
via Sequencing giant Illumina on Thursday announced that it will take a $1.47 billion hit in the second quarter of 2024 related to the recently completed spinoff of cancer testing company Grail.

article source
 

<